Table 1.
Distribution of FasL and Fas results according to culture, histology, HIV, BCG, age and gender results
| FasL postive n | FasL negative*n | Fas positive n | Fas negative*n | |
|---|---|---|---|---|
| Culture positive | 3 | 23 | 4 | 21 |
| M. tuberculosis | 0 | 9 | 0 | 8 |
| M. bovis | 0 | 5 | 0 | 5 |
| Atypical | 3 | 9 | 3 | 9 |
| Culture negative | 26 | 78 | 6 | 85 |
| Granulomas present | 6 | 3 | 1 | 8 |
| Granulomas absent | 0 | 2 | 1 | 1 |
| HIV–TB-coinfected | 2 | 7 | 1 | 6 |
| HIV-negative | 17 | 61 | 7 | 62 |
| BCG-positive | 24 | 77 | 6 | 81 |
| BCG negative | 6 | 22 | 5 | 23 |
| Females | 20 | 54 | 6 | 59 |
| Males | 10 | 50 | 5 | 50 |
*
Negative are the values below the cut-off value based on the 95th percentile values of proteins in the healthy control serum.
n = number of patients in each group. The total number of patients among groups varies because of non-availability of all the information for every patient.